McGill University and Génome Québec Innovation Centre

740, Dr. Penfield Avenue, Room 7104
Montréal (Québec) Canada
H3A 0G1

Phone: 514-398-7211
Fax: 514-398-1790

Innovation Centre

Major funding for the McGill University and Génome Québec Innovation Centre is provided by the Government of Canada through Genome Canada, and also the ministère du Développement Économique, de l'Innovation et de l'Exportation of Québec.

The McGill University and Génome Québec Innovation Centre is a world class research facility for genomics and proteomics. Founded in 2002, the Centre has developed a world-renowned expertise in complex genetic disorders such as cardiac disease, asthma and Type 2 diabetes, and has become a resource and a networking site for various research initiatives in human health, forestry, infectious diseases, agriculture and environment.

Ambitious projects in recent years are a testimony of the ability of Génome Québec to provide data of exceptional quality in the pursuit of various genomics studies. The Innovation Centre provides complete DNA and RNA analysis services, from a few samples to several tens of thousands per week. Large-scale genomics and proteomics services at the Innovation Centre are articulated around sequencing (including massively parallel sequencing), genotyping, functional genomics and extraction supported by a solid infrastructure, tools (Nanuq), unique expertise in bioinformatics and nucleic acid extraction. The Innovation Center also hosts the Canadian Center for Computational Genomics (C3G) which offers bioinformatics services.

All services work in parallel to provide comprehensive, reliable services to the Québec, Canadian and international scientific community. Located on the campus of McGill University in the heart of Montreal, the Innovation Centre acts as a vast resource of knowledge and technology to the academic and industrial sectors.

International Scientific Advisory Board (as of April 1st 2011)

The McGill University and Génome Québec Innovation Centre is proud to be supported by an international Scientific Advisory Board (iSAB).

Lon Cardon, PhD, FMedSci
Senior Vice President, Genetics and Quantitative Sciences
Pennsylvania, USA
Expertise: Bioinformatics and quantitative; biology pharmaceutical applications

Professor Jonathan Knowles, PhD
Translational Medicine, EPFL, Switzerland
Finnish Institute for Molecular Medicine, University of Helsinki, Finland
Translational Medicine, University of Oxford, UK
Vice Chairman and CSO of Caris Life Sciences
Expertise: Translational medicine, diagnostics and pharmaceutical applications

Michel Georges, PhD
Animal Genomics
GIGA-R & Faculty of Veterinary Medicine
University of Liège (B34)
Expertise: Animal genetics, quantitative genetics and epigenomics

Professor Mathias Uhlen, PhD
Royal Institute of Technology (KTH)
Stockholm, Sweden
Expertise: Genomic technologies and proteomics

Edison Liu, PhD
Executive Director
Genome Institute of Singapore
Expertise: Genomic methodologies and cancer genomics

Dr. Mark Lathrop
Scientific Director

Dr. Catalina Lopez-Correa (ex officio)
VP Scientific Affairs, Génome Québec

Dr. Naveed Aziz (ex officio)
Genome Canada